AbbVie ABBV has built a robust neuroscience franchise over the years. Though the segment was initially heralded by ...

AbbVie ABBV has been on an acquisition spree in the past couple of years to bolster the early-stage pipeline, which should drive long-term growth. Though immunology remains its core area, the company ...